APO Research
Talk to an analyst

APO RESEARCH · REPORT

Depression Treatment Device

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Depression Treatment Device Industry Growth and Trends Forecast to 2032

4 July 2026107 pages

Choose your research edition.

Industry ResearchDepression Treatment Device Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Depression Treatment Device Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Depression Treatment Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Depression Treatment Device Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Depression Treatment Device Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Depression Treatment Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Depression Treatment Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Depression Treatment Device is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Depression Treatment Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Depression Treatment Device include Alpha-Stim, BrainsWay, Caputron Medical, Electromedical Products International, Inc., Fisher Wallace Laboratories, Flow Neuroscience, Flow Neuroscience AB, Ginger and INNOVATIVE NEUROLOGICAL Devices LLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Depression Treatment Device market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Depression Treatment Device market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Depression Treatment Device market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Depression Treatment Device.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Depression Treatment Device market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Depression Treatment Device Market by Company

Alpha-Stim

BrainsWay

Caputron Medical

Electromedical Products International, Inc.

Fisher Wallace Laboratories

Flow Neuroscience

Flow Neuroscience AB

Ginger

INNOVATIVE NEUROLOGICAL Devices LLC

Magnus Medical

Neurolief

Neuronetics

NeuroStar

The Magstim Company Limited

Depression Treatment Device Segment by Type

Transcranial Direct Current Stimulation (tDCS)

Transcranial Random Noise Stimulation (tRNS)

Transcranial Pulsed Current Stimulation (tPCS)

Transcranial Alternating Current Stimulation (tACS)

Electroconvulsive therapy (ECT)

Others

Depression Treatment Device Segment by Application

Hospital

Clinic

Others

Depression Treatment Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Depression Treatment Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Depression Treatment Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Depression Treatment Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Depression Treatment Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Depression Treatment Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Transcranial Direct Current Stimulation (tDCS) Table 2. Major Company of Transcranial Random Noise Stimulation (tRNS) Table 3. Major Company of Transcranial Pulsed Current Stimulation (tPCS) Table 4. Major Company of Transcranial Alternating Current Stimulation (tACS) Table 5. Major Company of Electroconvulsive therapy (ECT) Table 6. Major Company of Others Table 7. Global Depression Treatment Device Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Depression Treatment Device Sales by Type (2021-2026) & (k units) Table 9. Global Depression Treatment Device Sales Market Share in Volume by Type (2021-2026) Table 10. Global Depression Treatment Device Sales by Type (2021-2026) & (US$ Million) Table 11. Global Depression Treatment Device Sales Market Share in Value by Type (2021-2026) Table 12. Global Depression Treatment Device Price by Type (2021-2026) & (USD/unit) Table 13. Global Depression Treatment Device Sales by Type (2027-2032) & (k units) Table 14. Global Depression Treatment Device Sales Market Share in Volume by Type (2027-2032) Table 15. Global Depression Treatment Device Sales by Type (2027-2032) & (US$ Million) Table 16. Global Depression Treatment Device Sales Market Share in Value by Type (2027-2032) Table 17. Global Depression Treatment Device Price by Type (2027-2032) & (USD/unit) Table 18. North America Depression Treatment Device Sales by Type (2021-2026) & (k units) Table 19. North America Depression Treatment Device Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Depression Treatment Device Sales by Type (2021-2026) & (k units) Table 21. Europe Depression Treatment Device Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Depression Treatment Device Sales by Type (2021-2026) & (k units) Table 23. Asia-Pacific Depression Treatment Device Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Depression Treatment Device Sales by Type (2021-2026) & (k units) Table 25. Latin America Depression Treatment Device Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Depression Treatment Device Sales by Type (2021-2026) & (k units) Table 27. Middle East and Africa Depression Treatment Device Sales by Type (2021-2026) & (US$ Million) Table 28. Depression Treatment Device Industry Trends Table 29. Depression Treatment Device Industry Drivers Table 30. Depression Treatment Device Industry Opportunities and Challenges Table 31. Depression Treatment Device Industry Restraints Table 32. Global Depression Treatment Device Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Depression Treatment Device Revenue Market Share by Company (2021-2026) Table 34. Global Depression Treatment Device Sales by Company (2021-2026) & (k units) Table 35. Global Depression Treatment Device Sales Share by Company (2021-2026) Table 36. Global Depression Treatment Device Market Price by Company (2021-2026) & (USD/unit) Table 37. Global Depression Treatment Device Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Depression Treatment Device Major Company Production Sites and Headquarters Table 39. Global Depression Treatment Device Company, Product Type & Application Table 40. Global Depression Treatment Device Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Depression Treatment Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Depression Treatment Device Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Depression Treatment Device Sales by Region (2021-2026) & (k units) Table 45. Global Depression Treatment Device Sales Market Share in Volume by Region (2021-2026) Table 46. Global Depression Treatment Device Sales by Region (2021-2026) & (US$ Million) Table 47. Global Depression Treatment Device Sales Market Share in Value by Region (2021-2026) Table 48. Global Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 49. Global Depression Treatment Device Sales by Region (2027-2032) & (k units) Table 50. Global Depression Treatment Device Sales Market Share in Volume by Region (2027-2032) Table 51. Global Depression Treatment Device Sales by Region (2027-2032) & (US$ Million) Table 52. Global Depression Treatment Device Sales Market Share in Value by Region (2027-2032) Table 53. Global Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 54. Global Depression Treatment Device Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Depression Treatment Device Sales by Application (2021-2026) & (k units) Table 56. Global Depression Treatment Device Sales Market Share in Volume by Application (2021-2026) Table 57. Global Depression Treatment Device Sales by Application (2021-2026) & (US$ Million) Table 58. Global Depression Treatment Device Sales Market Share in Value by Application (2021-2026) Table 59. Global Depression Treatment Device Price by Application (2021-2026) & (USD/unit) Table 60. Global Depression Treatment Device Sales by Application (2027-2032) & (k units) Table 61. Global Depression Treatment Device Sales Market Share in Volume by Application (2027-2032) Table 62. Global Depression Treatment Device Sales by Application (2027-2032) & (US$ Million) Table 63. Global Depression Treatment Device Sales Market Share in Value by Application (2027-2032) Table 64. Global Depression Treatment Device Price by Application (2027-2032) & (USD/unit) Table 65. North America Depression Treatment Device Sales by Application (2021-2026) & (k units) Table 66. North America Depression Treatment Device Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Depression Treatment Device Sales by Application (2021-2026) & (k units) Table 68. Europe Depression Treatment Device Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Depression Treatment Device Sales by Application (2021-2026) & (k units) Table 70. Asia-Pacific Depression Treatment Device Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Depression Treatment Device Sales by Application (2021-2026) & (k units) Table 72. Latin America Depression Treatment Device Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Depression Treatment Device Sales by Application (2021-2026) & (k units) Table 74. Middle East and Africa Depression Treatment Device Sales by Application (2021-2026) & (US$ Million) Table 75. Alpha-Stim Company Information Table 76. Alpha-Stim Business Overview Table 77. Alpha-Stim Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Alpha-Stim Depression Treatment Device Product Portfolio Table 79. Alpha-Stim Recent Development Table 80. BrainsWay Company Information Table 81. BrainsWay Business Overview Table 82. BrainsWay Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. BrainsWay Depression Treatment Device Product Portfolio Table 84. BrainsWay Recent Development Table 85. Caputron Medical Company Information Table 86. Caputron Medical Business Overview Table 87. Caputron Medical Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Caputron Medical Depression Treatment Device Product Portfolio Table 89. Caputron Medical Recent Development Table 90. Electromedical Products International, Inc. Company Information Table 91. Electromedical Products International, Inc. Business Overview Table 92. Electromedical Products International, Inc. Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Electromedical Products International, Inc. Depression Treatment Device Product Portfolio Table 94. Electromedical Products International, Inc. Recent Development Table 95. Fisher Wallace Laboratories Company Information Table 96. Fisher Wallace Laboratories Business Overview Table 97. Fisher Wallace Laboratories Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Fisher Wallace Laboratories Depression Treatment Device Product Portfolio Table 99. Fisher Wallace Laboratories Recent Development Table 100. Flow Neuroscience Company Information Table 101. Flow Neuroscience Business Overview Table 102. Flow Neuroscience Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Flow Neuroscience Depression Treatment Device Product Portfolio Table 104. Flow Neuroscience Recent Development Table 105. Flow Neuroscience AB Company Information Table 106. Flow Neuroscience AB Business Overview Table 107. Flow Neuroscience AB Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Flow Neuroscience AB Depression Treatment Device Product Portfolio Table 109. Flow Neuroscience AB Recent Development Table 110. Ginger Company Information Table 111. Ginger Business Overview Table 112. Ginger Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Ginger Depression Treatment Device Product Portfolio Table 114. Ginger Recent Development Table 115. INNOVATIVE NEUROLOGICAL Devices LLC Company Information Table 116. INNOVATIVE NEUROLOGICAL Devices LLC Business Overview Table 117. INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Product Portfolio Table 119. INNOVATIVE NEUROLOGICAL Devices LLC Recent Development Table 120. Magnus Medical Company Information Table 121. Magnus Medical Business Overview Table 122. Magnus Medical Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Magnus Medical Depression Treatment Device Product Portfolio Table 124. Magnus Medical Recent Development Table 125. Neurolief Company Information Table 126. Neurolief Business Overview Table 127. Neurolief Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Neurolief Depression Treatment Device Product Portfolio Table 129. Neurolief Recent Development Table 130. Neuronetics Company Information Table 131. Neuronetics Business Overview Table 132. Neuronetics Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Neuronetics Depression Treatment Device Product Portfolio Table 134. Neuronetics Recent Development Table 135. NeuroStar Company Information Table 136. NeuroStar Business Overview Table 137. NeuroStar Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. NeuroStar Depression Treatment Device Product Portfolio Table 139. NeuroStar Recent Development Table 140. The Magstim Company Limited Company Information Table 141. The Magstim Company Limited Business Overview Table 142. The Magstim Company Limited Depression Treatment Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. The Magstim Company Limited Depression Treatment Device Product Portfolio Table 144. The Magstim Company Limited Recent Development Table 145. North America Depression Treatment Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 146. North America Depression Treatment Device Sales by Country (2021-2026) & (k units) Table 147. North America Depression Treatment Device Sales Market Share by Country (2021-2026) Table 148. North America Depression Treatment Device Sales Forecast by Country (2027-2032) & (k units) Table 149. North America Depression Treatment Device Sales Market Share Forecast by Country (2027-2032) Table 150. North America Depression Treatment Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. North America Depression Treatment Device Market Size by Country (2021-2026) & (US$ Million) Table 152. North America Depression Treatment Device Market Share by Country (2021-2026) Table 153. North America Depression Treatment Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. North America Depression Treatment Device Market Share Forecast by Country (2027-2032) Table 155. Europe Depression Treatment Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 156. Europe Depression Treatment Device Sales by Country (2021-2026) & (k units) Table 157. Europe Depression Treatment Device Sales Market Share by Country (2021-2026) Table 158. Europe Depression Treatment Device Sales Forecast by Country (2027-2032) & (k units) Table 159. Europe Depression Treatment Device Sales Market Share Forecast by Country (2027-2032) Table 160. Europe Depression Treatment Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Europe Depression Treatment Device Market Size by Country (2021-2026) & (US$ Million) Table 162. Europe Depression Treatment Device Market Share by Country (2021-2026) Table 163. Europe Depression Treatment Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Europe Depression Treatment Device Market Share Forecast by Country (2027-2032) Table 165. Asia-Pacific Depression Treatment Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 166. Asia-Pacific Depression Treatment Device Sales by Country (2021-2026) & (k units) Table 167. Asia-Pacific Depression Treatment Device Sales Market Share by Country (2021-2026) Table 168. Asia-Pacific Depression Treatment Device Sales Forecast by Country (2027-2032) & (k units) Table 169. Asia-Pacific Depression Treatment Device Sales Market Share Forecast by Country (2027-2032) Table 170. Asia-Pacific Depression Treatment Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Asia-Pacific Depression Treatment Device Market Size by Country (2021-2026) & (US$ Million) Table 172. Asia-Pacific Depression Treatment Device Market Share by Country (2021-2026) Table 173. Asia-Pacific Depression Treatment Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Asia-Pacific Depression Treatment Device Market Share Forecast by Country (2027-2032) Table 175. Latin America Depression Treatment Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 176. Latin America Depression Treatment Device Sales by Country (2021-2026) & (k units) Table 177. Latin America Depression Treatment Device Sales Market Share by Country (2021-2026) Table 178. Latin America Depression Treatment Device Sales Forecast by Country (2027-2032) & (k units) Table 179. Latin America Depression Treatment Device Sales Market Share Forecast by Country (2027-2032) Table 180. Latin America Depression Treatment Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 181. Latin America Depression Treatment Device Market Size by Country (2021-2026) & (US$ Million) Table 182. Latin America Depression Treatment Device Market Share by Country (2021-2026) Table 183. Latin America Depression Treatment Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 184. Latin America Depression Treatment Device Market Share Forecast by Country (2027-2032) Table 185. Middle East and Africa Depression Treatment Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 186. Middle East and Africa Depression Treatment Device Sales by Country (2021-2026) & (k units) Table 187. Middle East and Africa Depression Treatment Device Sales Market Share by Country (2021-2026) Table 188. Middle East and Africa Depression Treatment Device Sales Forecast by Country (2027-2032) & (k units) Table 189. Middle East and Africa Depression Treatment Device Sales Market Share Forecast by Country (2027-2032) Table 190. Middle East and Africa Depression Treatment Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 191. Middle East and Africa Depression Treatment Device Market Size by Country (2021-2026) & (US$ Million) Table 192. Middle East and Africa Depression Treatment Device Market Share by Country (2021-2026) Table 193. Middle East and Africa Depression Treatment Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 194. Middle East and Africa Depression Treatment Device Market Share Forecast by Country (2027-2032) Table 195. Key Raw Materials Table 196. Raw Materials Key Suppliers Table 197. Depression Treatment Device Distributors List Table 198. Depression Treatment Device Customers List Table 199. Research Programs/Design for This Report Table 200. Authors List of This Report Table 201. Secondary Sources Table 202. Primary Sources List of Figures Figure 1. Depression Treatment Device Image Figure 2. Global Depression Treatment Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Depression Treatment Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Depression Treatment Device Sales (2021-2032) & (k units) Figure 5. Transcranial Direct Current Stimulation (tDCS) Image Figure 6. Global Transcranial Direct Current Stimulation (tDCS) Sales YoY Growth (2021-2032) & (k units) Figure 7. Transcranial Random Noise Stimulation (tRNS) Image Figure 8. Global Transcranial Random Noise Stimulation (tRNS) Sales YoY Growth (2021-2032) & (k units) Figure 9. Transcranial Pulsed Current Stimulation (tPCS) Image Figure 10. Global Transcranial Pulsed Current Stimulation (tPCS) Sales YoY Growth (2021-2032) & (k units) Figure 11. Transcranial Alternating Current Stimulation (tACS) Image Figure 12. Global Transcranial Alternating Current Stimulation (tACS) Sales YoY Growth (2021-2032) & (k units) Figure 13. Electroconvulsive therapy (ECT) Image Figure 14. Global Electroconvulsive therapy (ECT) Sales YoY Growth (2021-2032) & (k units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 17. Global Depression Treatment Device Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Depression Treatment Device Market Share by Type 2025 VS 2032 Figure 19. North America Depression Treatment Device Sales Market Share in Volume by Type in 2025 Figure 20. North America Depression Treatment Device Sales Market Share in Value by Type in 2025 Figure 21. Europe Depression Treatment Device Sales Market Share in Volume by Type in 2025 Figure 22. Europe Depression Treatment Device Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Depression Treatment Device Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Depression Treatment Device Sales Market Share in Value by Type in 2025 Figure 25. Latin America Depression Treatment Device Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Depression Treatment Device Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Depression Treatment Device Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Depression Treatment Device Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Depression Treatment Device Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 33. Clinic Image Figure 34. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Depression Treatment Device Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Depression Treatment Device Market Share by Application 2025 VS 2032 Figure 39. North America Depression Treatment Device Sales Market Share in Volume by Application in 2025 Figure 40. North America Depression Treatment Device Sales Market Share in Value by Application in 2025 Figure 41. Europe Depression Treatment Device Sales Market Share in Volume by Application in 2025 Figure 42. Europe Depression Treatment Device Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Depression Treatment Device Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Depression Treatment Device Sales Market Share in Value by Application in 2025 Figure 45. Latin America Depression Treatment Device Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Depression Treatment Device Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Depression Treatment Device Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Depression Treatment Device Sales Market Share in Value by Application in 2025 Figure 49. North America Depression Treatment Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Depression Treatment Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Depression Treatment Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Depression Treatment Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Depression Treatment Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Depression Treatment Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Depression Treatment Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Depression Treatment Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Depression Treatment Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Depression Treatment Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Depression Treatment Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Depression Treatment Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Depression Treatment Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Depression Treatment Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Depression Treatment Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Depression Treatment Device Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Depression Treatment Device Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Transcranial Direct Current Stimulation (tDCS)
  • Transcranial Random Noise Stimulation (tRNS)
  • Transcranial Pulsed Current Stimulation (tPCS)
  • Transcranial Alternating Current Stimulation (tACS)
  • Electroconvulsive therapy (ECT)
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Alpha-Stim
  • BrainsWay
  • Caputron Medical
  • Electromedical Products International, Inc.
  • Fisher Wallace Laboratories
  • Flow Neuroscience
  • Flow Neuroscience AB
  • Ginger
  • INNOVATIVE NEUROLOGICAL Devices LLC
  • Magnus Medical
  • Neurolief
  • Neuronetics
  • NeuroStar
  • The Magstim Company Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Depression Treatment Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Depression Treatment Device Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Depression Treatment Device Market by Type
  6. 1.3.1 Transcranial Direct Current Stimulation (tDCS)
  7. 1.3.2 Transcranial Random Noise Stimulation (tRNS)
  8. 1.3.3 Transcranial Pulsed Current Stimulation (tPCS)
  9. 1.3.4 Transcranial Alternating Current Stimulation (tACS)
  10. 1.3.5 Electroconvulsive therapy (ECT)
  11. 1.3.6 Others
  12. 1.4 Global Depression Treatment Device Market Size by Type
  13. 1.4.1 Global Depression Treatment Device Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Depression Treatment Device Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Depression Treatment Device Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Depression Treatment Device Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Depression Treatment Device Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Depression Treatment Device Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Depression Treatment Device Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Depression Treatment Device Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Depression Treatment Device Industry Trends
  2. 2.2 Depression Treatment Device Industry Drivers
  3. 2.3 Depression Treatment Device Industry Opportunities and Challenges
  4. 2.4 Depression Treatment Device Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Depression Treatment Device Revenue (2021-2026)
  2. 3.2 Global Top Players by Depression Treatment Device Sales (2021-2026)
  3. 3.3 Global Top Players by Depression Treatment Device Price (2021-2026)
  4. 3.4 Global Depression Treatment Device Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Depression Treatment Device Major Company Production Sites & Headquarters
  6. 3.6 Global Depression Treatment Device Company, Product Type & Application
  7. 3.7 Global Depression Treatment Device Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Depression Treatment Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Depression Treatment Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Depression Treatment Device Tier 1, Tier 2, and Tier 3
4 Depression Treatment Device Regional Status and Outlook
  1. 4.1 Global Depression Treatment Device Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Depression Treatment Device Historic Market Size by Region
  3. 4.2.1 Global Depression Treatment Device Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Depression Treatment Device Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Depression Treatment Device Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Depression Treatment Device Forecasted Market Size by Region
  7. 4.3.1 Global Depression Treatment Device Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Depression Treatment Device Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Depression Treatment Device Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Depression Treatment Device by Application
  1. 5.1 Depression Treatment Device Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Depression Treatment Device Market Size by Application
  6. 5.2.1 Global Depression Treatment Device Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Depression Treatment Device Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Depression Treatment Device Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Depression Treatment Device Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Depression Treatment Device Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Depression Treatment Device Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Depression Treatment Device Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Depression Treatment Device Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alpha-Stim
  2. 6.1.1 Alpha-Stim Company Information
  3. 6.1.2 Alpha-Stim Business Overview
  4. 6.1.3 Alpha-Stim Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alpha-Stim Depression Treatment Device Product Portfolio
  6. 6.1.5 Alpha-Stim Recent Developments
  7. 6.2 BrainsWay
  8. 6.2.1 BrainsWay Company Information
  9. 6.2.2 BrainsWay Business Overview
  10. 6.2.3 BrainsWay Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 BrainsWay Depression Treatment Device Product Portfolio
  12. 6.2.5 BrainsWay Recent Developments
  13. 6.3 Caputron Medical
  14. 6.3.1 Caputron Medical Company Information
  15. 6.3.2 Caputron Medical Business Overview
  16. 6.3.3 Caputron Medical Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Caputron Medical Depression Treatment Device Product Portfolio
  18. 6.3.5 Caputron Medical Recent Developments
  19. 6.4 Electromedical Products International, Inc.
  20. 6.4.1 Electromedical Products International, Inc. Company Information
  21. 6.4.2 Electromedical Products International, Inc. Business Overview
  22. 6.4.3 Electromedical Products International, Inc. Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Electromedical Products International, Inc. Depression Treatment Device Product Portfolio
  24. 6.4.5 Electromedical Products International, Inc. Recent Developments
  25. 6.5 Fisher Wallace Laboratories
  26. 6.5.1 Fisher Wallace Laboratories Company Information
  27. 6.5.2 Fisher Wallace Laboratories Business Overview
  28. 6.5.3 Fisher Wallace Laboratories Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Fisher Wallace Laboratories Depression Treatment Device Product Portfolio
  30. 6.5.5 Fisher Wallace Laboratories Recent Developments
  31. 6.6 Flow Neuroscience
  32. 6.6.1 Flow Neuroscience Company Information
  33. 6.6.2 Flow Neuroscience Business Overview
  34. 6.6.3 Flow Neuroscience Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Flow Neuroscience Depression Treatment Device Product Portfolio
  36. 6.6.5 Flow Neuroscience Recent Developments
  37. 6.7 Flow Neuroscience AB
  38. 6.7.1 Flow Neuroscience AB Company Information
  39. 6.7.2 Flow Neuroscience AB Business Overview
  40. 6.7.3 Flow Neuroscience AB Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Flow Neuroscience AB Depression Treatment Device Product Portfolio
  42. 6.7.5 Flow Neuroscience AB Recent Developments
  43. 6.8 Ginger
  44. 6.8.1 Ginger Company Information
  45. 6.8.2 Ginger Business Overview
  46. 6.8.3 Ginger Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ginger Depression Treatment Device Product Portfolio
  48. 6.8.5 Ginger Recent Developments
  49. 6.9 INNOVATIVE NEUROLOGICAL Devices LLC
  50. 6.9.1 INNOVATIVE NEUROLOGICAL Devices LLC Company Information
  51. 6.9.2 INNOVATIVE NEUROLOGICAL Devices LLC Business Overview
  52. 6.9.3 INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Product Portfolio
  54. 6.9.5 INNOVATIVE NEUROLOGICAL Devices LLC Recent Developments
  55. 6.10 Magnus Medical
  56. 6.10.1 Magnus Medical Company Information
  57. 6.10.2 Magnus Medical Business Overview
  58. 6.10.3 Magnus Medical Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Magnus Medical Depression Treatment Device Product Portfolio
  60. 6.10.5 Magnus Medical Recent Developments
  61. 6.11 Neurolief
  62. 6.11.1 Neurolief Company Information
  63. 6.11.2 Neurolief Business Overview
  64. 6.11.3 Neurolief Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Neurolief Depression Treatment Device Product Portfolio
  66. 6.11.5 Neurolief Recent Developments
  67. 6.12 Neuronetics
  68. 6.12.1 Neuronetics Company Information
  69. 6.12.2 Neuronetics Business Overview
  70. 6.12.3 Neuronetics Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Neuronetics Depression Treatment Device Product Portfolio
  72. 6.12.5 Neuronetics Recent Developments
  73. 6.13 NeuroStar
  74. 6.13.1 NeuroStar Company Information
  75. 6.13.2 NeuroStar Business Overview
  76. 6.13.3 NeuroStar Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 NeuroStar Depression Treatment Device Product Portfolio
  78. 6.13.5 NeuroStar Recent Developments
  79. 6.14 The Magstim Company Limited
  80. 6.14.1 The Magstim Company Limited Company Information
  81. 6.14.2 The Magstim Company Limited Business Overview
  82. 6.14.3 The Magstim Company Limited Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 The Magstim Company Limited Depression Treatment Device Product Portfolio
  84. 6.14.5 The Magstim Company Limited Recent Developments
7 North America by Country
  1. 7.1 North America Depression Treatment Device Sales by Country
  2. 7.1.1 North America Depression Treatment Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Depression Treatment Device Sales by Country (2021-2026)
  4. 7.1.3 North America Depression Treatment Device Sales Forecast by Country (2027-2032)
  5. 7.2 North America Depression Treatment Device Market Size by Country
  6. 7.2.1 North America Depression Treatment Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Depression Treatment Device Market Size by Country (2021-2026)
  8. 7.2.3 North America Depression Treatment Device Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Depression Treatment Device Sales by Country
  2. 8.1.1 Europe Depression Treatment Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Depression Treatment Device Sales by Country (2021-2026)
  4. 8.1.3 Europe Depression Treatment Device Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Depression Treatment Device Market Size by Country
  6. 8.2.1 Europe Depression Treatment Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Depression Treatment Device Market Size by Country (2021-2026)
  8. 8.2.3 Europe Depression Treatment Device Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Depression Treatment Device Sales by Country
  2. 9.1.1 Asia-Pacific Depression Treatment Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Depression Treatment Device Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Depression Treatment Device Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Depression Treatment Device Market Size by Country
  6. 9.2.1 Asia-Pacific Depression Treatment Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Depression Treatment Device Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Depression Treatment Device Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Depression Treatment Device Sales by Country
  2. 10.1.1 South America Depression Treatment Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Depression Treatment Device Sales by Country (2021-2026)
  4. 10.1.3 South America Depression Treatment Device Sales Forecast by Country (2027-2032)
  5. 10.2 South America Depression Treatment Device Market Size by Country
  6. 10.2.1 South America Depression Treatment Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Depression Treatment Device Market Size by Country (2021-2026)
  8. 10.2.3 South America Depression Treatment Device Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Depression Treatment Device Sales by Country
  2. 11.1.1 Middle East and Africa Depression Treatment Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Depression Treatment Device Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Depression Treatment Device Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Depression Treatment Device Market Size by Country
  6. 11.2.1 Middle East and Africa Depression Treatment Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Depression Treatment Device Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Depression Treatment Device Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Depression Treatment Device Value Chain Analysis
  2. 12.1.1 Depression Treatment Device Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Depression Treatment Device Production Mode & Process
  7. 12.2 Depression Treatment Device Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Depression Treatment Device Distributors
  10. 12.2.3 Depression Treatment Device Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst